Agios Pharmaceuticals Inc (NASDAQ:AGIO)

123.23
Delayed Data
As of May 27
 +4.18 / +3.51%
Today’s Change
32.66
Today|||52-Week Range
138.85
+9.99%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Celgene Corp
Buy12/16/2014228,645$110.75$25.3M+14.66%
Biller Scott
Chief Scientific Officer
Sale9/19/201437,996$50.45$1.9M+151.95%
Schenkein David Paul
Chief Executive Officer
Sale9/26/201430,000$62.68$1.9M+93.27%
Schenkein David Paul
Chief Executive Officer
Sale9/26/201430,000$62.68$1.9M+93.27%
Goddard Glenn /archemix/
Senior Vice President-Finance
Sale2/09/201515,000$105.81$1.6M+16.30%
Higgons John Duncan
Chief Operating Officer
Sale1/02/201512,000$110.08$1.3M+12.27%
Higgons John Duncan
Chief Operating Officer
Sale1/02/201512,000$110.08$1.3M+12.27%
Higgons John Duncan
Chief Operating Officer
Sale12/01/201412,000$97.03$1.2M+28.00%
Goddard Glenn /archemix/
Senior Vice President-Finance
Sale3/16/201510,000$106.24$1.1M+15.76%
Higgons John Duncan
Chief Operating Officer
Sale11/03/201413,000$81.71$1.1M+48.34%
Page of 13

To view my watchlist

Not a member yet?

Sign up now for a free account